Literature DB >> 24276522

Long-term outcome after aneurysmal subarachnoid hemorrhage-risks of vascular events, death from cancer and all-cause death.

Dennis J Nieuwkamp1, Arno de Wilde, Marieke J H Wermer, Ale Algra, Gabriël J E Rinkel.   

Abstract

Smoking and hypertension are risk factors for aneurysmal subarachnoid hemorrhage (aSAH), but also for other cardiovascular diseases and cancer. Few prospective data are available on the very long term risks of vascular diseases and vascular, cancer-related and overall death after aSAH. We determined vascular events and survival status in 1,765 patients with aSAH admitted to our center from 1985 to 2010. Cumulative risks were estimated with survival analysis. We compared risks of vascular, cancer-related and all-cause death with the general population with standardized mortality ratios (SMRs). Incidences of vascular events and death were compared with those after TIA/minor stroke. Conditional on surviving 3 months after aSAH, the risk of death was 8.7 % (95 % CI 7.3-10.1) within 5 years, 17.9 % (16.1-19.9) within 10 years, 29.5 % (27.3-31.8) within 15 years, and 43.6 % (41.2-46.1) within 20 years after SAH. The SMR for all-cause death was 1.8 (1.6-2.1), for vascular death 2.0 (95 % CI 1.6-2.5) and for cancer-related death 1.2 (0.9-1.5; sensitivity analysis 1.4; 95 % CI 1.1-1.8). The increased SMR for all-cause death persevered up to 20 years after aSAH. Compared with TIA/minor stroke patients, the age- and sex-adjusted cumulative incidence on vascular events was lower for aSAH patients [hazard ratio (HR) 0.48; 95 % CI 0.40-0.57); the HR for all-cause death was 0.96 (95 % CI 0.84-1.10). After aSAH, risks of vascular events and death, and probably also that of cancer-related death, are higher than in the general population. Although the long-term risk of vascular events was lower in aSAH patients than in TIA/minor stroke patients, the risk of death was similar.

Entities:  

Mesh:

Year:  2013        PMID: 24276522     DOI: 10.1007/s00415-013-7192-8

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  19 in total

Review 1.  Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology.

Authors:  S M Grundy; R Pasternak; P Greenland; S Smith; V Fuster
Journal:  Circulation       Date:  1999-09-28       Impact factor: 29.690

2.  Long-term excess mortality of 244 familial and 1502 sporadic one-year survivors of aneurysmal subarachnoid hemorrhage compared with a matched Eastern Finnish catchment population.

Authors:  Terhi Huttunen; Mikael von und Zu Fraunberg; Timo Koivisto; Antti Ronkainen; Jaakko Rinne; Risto Sankila; Karri Seppä; Juha E Jääskeläinen
Journal:  Neurosurgery       Date:  2011-01       Impact factor: 4.654

3.  Incidence of recurrent subarachnoid hemorrhage after clipping for ruptured intracranial aneurysms.

Authors:  Marieke J H Wermer; Paut Greebe; Ale Algra; Gabriël J E Rinkel
Journal:  Stroke       Date:  2005-10-06       Impact factor: 7.914

4.  Evidence for excess long-term mortality after treated subarachnoid hemorrhage.

Authors:  A Ronkainen; M Niskanen; J Rinne; T Koivisto; J Hernesniemi; M Vapalahti
Journal:  Stroke       Date:  2001-12-01       Impact factor: 7.914

5.  Epidemiology of aneurysmal subarachnoid hemorrhage in Australia and New Zealand: incidence and case fatality from the Australasian Cooperative Research on Subarachnoid Hemorrhage Study (ACROSS).

Authors: 
Journal:  Stroke       Date:  2000-08       Impact factor: 7.914

6.  Excess mortality and cardiovascular events in patients surviving subarachnoid hemorrhage: a nationwide study in Sweden.

Authors:  Dennis J Nieuwkamp; Ale Algra; Paul Blomqvist; Johanna Adami; Erik Buskens; Hendrik Koffijberg; Gabriël J E Rinkel
Journal:  Stroke       Date:  2011-02-17       Impact factor: 7.914

Review 7.  Long-term outcomes of patients with aneurysmal subarachnoid haemorrhage.

Authors:  Gabriel J E Rinkel; Ale Algra
Journal:  Lancet Neurol       Date:  2011-04       Impact factor: 44.182

8.  Attributable risk of common and rare determinants of subarachnoid hemorrhage.

Authors:  Y M Ruigrok; E Buskens; G J Rinkel
Journal:  Stroke       Date:  2001-05       Impact factor: 7.914

9.  Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: a meta-analysis.

Authors:  Dennis J Nieuwkamp; Larissa E Setz; Ale Algra; Francisca H H Linn; Nicolien K de Rooij; Gabriël J E Rinkel
Journal:  Lancet Neurol       Date:  2009-06-06       Impact factor: 44.182

10.  Long-term mortality and vascular event risk after aneurysmal subarachnoid haemorrhage.

Authors:  M J H Wermer; P Greebe; A Algra; G J E Rinkel
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-12       Impact factor: 10.154

View more
  5 in total

Review 1.  Stroke: an update.

Authors:  José M Ferro; Catarina Fonseca
Journal:  J Neurol       Date:  2014-08-07       Impact factor: 4.849

2.  SIRT3 Expression Decreases with Reactive Oxygen Species Generation in Rat Cortical Neurons during Early Brain Injury Induced by Experimental Subarachnoid Hemorrhage.

Authors:  Wei Huang; Yong Huang; Ren-Qiang Huang; Cheng-Guang Huang; Wen-Hao Wang; Jin-Mao Gu; Yan Dong
Journal:  Biomed Res Int       Date:  2016-12-08       Impact factor: 3.411

3.  Cardiac events within one year after a subarachnoid haemorrhage: The predictive value of troponin elevation after aneurysm occlusion.

Authors:  Annemarie Akkermans; Linda M Peelen; Judith A van Waes; Gabriël J Rinkel; Wilton A van Klei
Journal:  Eur J Prev Cardiol       Date:  2018-05-17       Impact factor: 7.804

Review 4.  Clinical application of interventional embolization in tumor-associated hemorrhage.

Authors:  Yi Chen; Yi Yang; Wen-Ji Xu; Yu-Jing Xin; Ya-Nan Wang; Xiang Zhou; Xiao Li
Journal:  Ann Transl Med       Date:  2020-03

5.  Short- and long-term outcome of patients with aneurysmal subarachnoid hemorrhage.

Authors:  Jaume Roquer; Elisa Cuadrado-Godia; Leopoldo Guimaraens; Gerardo Conesa; Ana Rodríguez-Campello; Jaume Capellades; María P García-Arnillas; Juan L Fernández-Candil; Carla Avellaneda-Gómez; Eva Giralt-Steinhauer; Jordi Jiménez-Conde; Carolina Soriano-Tárraga; Gloria Villalba-Martínez; Rosa M Vivanco-Hidalgo; Elio Vivas; Angel Ois
Journal:  Neurology       Date:  2020-08-13       Impact factor: 9.910

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.